Hillsdale Investment Management’s Mersana Therapeutics MRSN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-27,728	Closed	-$2.85M	–	616
2023 Q1	$2.85M	Hold	27,728	–	–	0.24%	136
2022 Q4	$4.06M	Buy	27,728 +108	+0.4%	+$15.8K	0.34%	113
2022 Q3	$4.67M	Buy	+27,620	New	+$4.67M	0.42%	82